N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
C31H22N8O2 — CID 53231258
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide
N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 53231258) has the molecular formula C31H22N8O2 and a molecular weight of 538.57 g/mol. Its IUPAC name is N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 53231258 |
| Molecular Formula | C31H22N8O2 |
| Molecular Weight | 538.57 g/mol |
| Exact Mass | 538.19 |
| IUPAC Name | N-[5-(1-methylindole-3-carbonyl)-2-phenyltriazol-4-yl]-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | Cn1cc(C(=O)c2nn(-c3ccccc3)nc2NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c2ccccc21 |
| InChI | InChI=1S/C31H22N8O2/c1-37-19-24(22-14-8-9-15-26(22)37)28(40)27-29(36-39(35-27)21-12-6-3-7-13-21)34-31(41)23-18-33-38-25(16-17-32-30(23)38)20-10-4-2-5-11-20/h2-19H,1H3,(H,34,36,41) |
| InChIKey | JRLLGHLBGRSATL-UHFFFAOYSA-N |
| XLogP | 4.95 |
| TPSA | 112.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 538.57 |
| LogP ≤ 5 | 4.95 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53231258 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.